Ander Sologuren

Pharmacokinetic-Pharmacodynamic Modelling of the Antihistaminic (H1) Effect of Bilastine

Nerea Jauregizar, Leire de la Fuente, María Luisa Lucero et al. · Clinical Pharmacokinetics · 2009 · 60 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

Lack of Significant Effect of Bilastine Administered at Therapeutic and Supratherapeutic Doses and Concomitantly With Ketoconazole on Ventricular Repolarization: Results of a Thorough QT Study (TQTS) With QT‐Concentration Analysis

Benoît Tyl, Meriam Kabbaj, Sara M. Azzam et al. · The Journal of Clinical Pharmacology · 2011 · 60 citations

Medicine, Pharmacology, Pharmacotherapy +16

Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency

Kenneth C. Lasseter, Ander Sologuren, Anna La Noce et al. · Clinical Drug Investigation · 2013 · 36 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Model Informed Pediatric Development Applied to Bilastine: Ontogenic PK Model Development, Dose Selection for First Time in Children and PK Study Design

Valvanera Vozmediano, Ander Sologuren, John C. Lukas et al. · Pharmaceutical Research · 2017 · 16 citations

Pharmacy, Pediatrics, Pharmacology +17

Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and/or urticaria

Ander Sologuren, R Viñas, Esther Cordón et al. · Allergy and Asthma Proceedings · 2018 · 15 citations

Life Sciences, Pharmacology, Pharmacotherapy +16